9532 Fair Value & Analysis
Consumer Defensive · Market cap 202M SAR
Fair value as of: Jul 31, 2026
From 21 valuation models · updated today
Share price −10.4% over the past month.
What matters now
- The price sits above even our optimistic bull case (1.04 SAR). The favourable scenario is already priced in.
- Solid but not exceptional quality (48/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (12 months)
12‑month range 1.65 SAR – 2.68 SAR · fair‑value band 0.5900 SAR – 1.04 SAR · the 2.15 SAR price screens above the 0.7900 SAR fair value. As of Jul 31, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
9532 (9532) currently trades at 2.15 SAR, while our model-based Fair Value estimate is 0.7900 SAR, implying the stock looks roughly 63.3% overvalued today. We read business quality at 48/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, 9532 generated revenue of 71.0M SAR at a net margin of 6.2%. Revenue grew 25.6% year over year. It earns a return on equity of 4.7%. Net debt stands at 41.1M SAR. Fundamentals as of Jul 31, 2026
Our scenario range runs from 0.5900 SAR (bear case) to 1.04 SAR (bull case); at 2.15 SAR, the current price sits above that range. The share trades about 25% below its 52-week high and 30% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -31% fair-value upside, at -63%, 9532 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
9532 reported revenue of 71.0M SAR in FY2025 versus 67.6M SAR in FY2021, a compound +1.2%/yr. Reported net income was 4.4M SAR in FY2025, compounding −1.9%/yr from FY2021.
Is 9532 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Beverages - Non-Alcoholic stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Coca-Cola Company CCC3 | €72.40 | €21.88 | -70% |
| PepsiCo, Inc PEP | C$21.09 | C$12.45 | -41% |
| Monster Beverage Corporation MNST | $91.21 | $40.91 | -55% |
| Nongfu Spring Co NNFSF | $5.34 | $9.53 | +78% |
| Coca-Cola Europacific Partners PLC CCEP | €84.70 | €85.41 | +1% |
| Coca-Cola FEMSA, S.A. C2CA34 | R$108.87 | R$48.98 | -55% |
| Keurig Dr Pepper Inc KDP | $31.70 | $21.94 | -31% |
| Coca-Cola HBC AG CCHGY | $61.59 | $48.93 | -21% |
| Arca Continental, S.A. EMBVF | $11.82 | $13.98 | +18% |
| Varun Beverages Limited VBL | ₹495.70 | ₹187.49 | -62% |
Compare 9532 with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is 9532 overvalued or undervalued?
What is the fair value of 9532?
What is the quality score of 9532?
What is the revenue of 9532?
What is the net profit margin of 9532?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track 9532 and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.